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α/β which might also reflect more uniformity in response 
perhaps more characteristic of lower proliferative or early-
stage disease. This has resulted in new efforts to test 
hypofractionation which have also been enabled by better 
dose localization achievable with image-guided Volumetric 
Modulated Arc Therapy. 
There is evidence that the LQ model becomes less reliable at 
doses per fraction < 1 Gy, due to possible low-dose hyper-
radiosensitivity, and also at > 6 Gy per fraction for reasons 
not yet understood though increasing vascular damage and 
immunological/inflammatory effects occur at higher doses 
per fraction. It is axiomatic that LQ must indeed 
overestimate effect at very high doses per fraction because 
the effective D0 would become unrealistically low. This 
makes the outcome of hypofractionated regimes less 
predictable: using LQ at high doses per fraction would be 
playing safe in predicting toxicity of hypofractionation, while 
overestimating the effect on the target malignancy, noting 
that possible hypoxia in a tumor could also limit the 
effectiveness of large dose fractions. 
    
 
Debate: Have we reached the technology edge in radiation 
therapy?  
 
 
SP-0507   
In radiotherapy, technology without radiobiology is like 
driving a Porsche at 40 kilometres per hourí 
A. Nahum1 
1The Clatterbridge Cancer Centre - Wirral NHS Foundation 
Trust, Physics Department, Bebington Wirral, United 
Kingdom  
 
Today’s external-beam radiotherapy (EBRT) is technologically 
sophisticated but radiobiologically primitive. Since the late 
1980s ‘Hi-tech’ has dominated EBRT at the expense of 
‘radiobiological intelligence’. Furthermore we have become 
slaves to the mantra  ‘evidence-based medicine’, with 
 evidence = phase-3 clinical trials: this ties our hands behind 
our backs. We prostrate ourselves before the ‘Collective 
Dose-Escalation Deity’ e.g. via advances such as MLCs, IMRT, 
even protons but largely reject individual dose-escalation 
based on (normal-tissue) patient DVHs   - this is illogical and 
does patients a disservice. We have become ‘hostages to 
commercial fortune’ – if the companies say ‘oh we cannot 
give you TCP or NTCP in our planning system in case someone 
sues us’ we meekly accept this!  This lamentable ‘worship of 
commercial interests’ is a negation of our dignity as scientists 
and our responsibility as medical practitioners. Today’s EBRT 
is ‘North Korean’ – instead it should be ‘South Korean’ i.e. 
based on enterprise and intelligence. Evolution equipped us 
with creative brains, which can do so much more than follow 
‘safety first’ protocols developed by committees. The ‘Hi-
tech’ gadgets of today are impressive but our use of them 
will remain largely pedestrian without the application of 
‘radiobiological intelligence’ – our patients expect no less.  
   
SP-0508   
Against the motion: No, new technological developments 
will always appear 
P. Munck af Rosenschöld1 
1Rigshospitalet, Department of Radiation Oncology, 
Copenhagen, Denmark  
  
The debate revolves around the impact of technology in 
radiotherapy (RT). RT as a field has a long tradition of high 
technology involvement, and practitioners are used to 
frequent technology advances. Recent technology advances 
include advanced imaging for planning and treatment 
verification, as well as rotational intensity modulation RT 
delivery. The ability to deliver the correct dose efficiently 
and with millimeter precision is now feasible at most modern 
RT departments. The question whether we have reached “the 
edge in radiotherapy” is therefore warranted. Even though 
the technology for planning and delivery has evolved, RT 
clinics rely much on manual procedures for tumor 
delineation, treatment planning, quality control test and 
treatment adaptation. Simultaneously, many RT clinics face 
the challenge of rising patient numbers to treat using the 
same equipment and with less staff. Further, most RT clinics 
lack systematic follow-up of treatment outcomes. I argue in 
this talk that new technology can improve RT cost-
effectiveness and patient outcomes. In addition, improved 
technology is warranted for safe personalized dose 
prescription and adapted radiation therapy. Technology 
advances can allow for automated procedures in the 
preparation of treatments, including delineation and planning 
Information technology solutions could automate the follow-
up procedures, including evaluation of quality of life, local 
control, patterns of relapse and survival.   
   
 
Symposium: MRI throughout the treatment chain  
 
 
SP-0509   
MR Imaging in Radiotherapy: The evolving role of the RTT 
G. Perkins1 
1Hamad Medical Corporation National Centre for Cancer Care 
& Research, Radiation Oncology, Doha, Qatar  
  
There is increasing interest and application of Magnetic 
Resonance Imaging simulation (MRI-SIM) into the radiotherapy 
localization and planning process. However, the knowledge 
base within the context of Radiation Therapy practice is still 
in development.  Further, workforce development and the 
training plans for RTTs working in this developing area of 
practice has been not yet been standardized. This session 
targeted at RTTs, aims to provide an overview of the issues 
involved in developing a service where MRI scans are acquired 
in the treatment position, for RT planning (MRI SIM). The 
session will review the basic principles of MR imaging, the 
rationale for its use in radiotherapy and typical pulse 
sequences and scan protocols used for radiotherapy 
localization (MR-SIM). The session will also provide 
an overview of MR scanner modifications and accessories 
utilized for MR-SIM. The typical clinical workflow for MR-SIM 
including patient preparation, safety issues, scan 
optimization and CT-MR image registration using clinical 
examples will be presented. An overview of common staffing 
models and training plans for RTT’s working in MR-SIM will be 
reviewed 
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CT is currently routinely combined with MRI in the planning 
of radiotherapy (RT) at many centers in Europe. MRI is mainly 
introduced into the RT workflow due to a superior 
delineation precision of target volume and organs at risks 
compared to CT. This procedure, however, introduces a 
systematic error arising from the registration between the 
two modalities. Removing the CT scan and basing the entire 
treatment workflow, i.e. simulation, planning and delivery on 
MRI as the sole modality, so-called MRI-only RT, would 
eliminate this registration error. Electron densities, however, 
need to be assigned to the MRI images for dose calculation 
and patient setup based on digitally reconstructed 
radiographs (DRRs).  Further, recent inventions such as the 
integrated MRI/PET and MRI/Linac systems have increased 
this need for attenuation map correction and plan adaptation 
based on the MRI. This presentation will present examples of 
the rationale behind MRI-only RT and review the past and 
current developments within this area. Further, the different 
strategies for assigning electron densities to the MR images in 
different parts of the body will be discussed.  
   
SP-0511   
MR linac, continuous IGRT during radiotherapy 
S.P.M. Crijns1 
1UMC Utrecht, Department of Radiation Oncology, Utrecht, 
The Netherlands  
 
In the current radiotherapy clinic MRI is used to support 
tumour and organ at risk delineations as well as tumour 
characterisation because of its good soft tissue 
contrast. Moreover, with MRI, soft-tissue structures can be 
visualised at high temporal resolution. 
Future integrated MRI/radiotherapy systems promise to 
visualise soft-tissue structures in real-time during radiation 
delivery. This opens possibilities to better tailor the 
treatment to the momentary patient anatomy. In this 
presentation, we will take a look at MRI-linac hardware and 
explore therapy delivery prospects that arise from several 
dedicated MR sequences. 
   
 
Symposium: Working smarter to create ‘my dream career’  
 
 
SP-0512   
A physicist’ perspective 
K. Tanderup1 
1Aarhus University Hospital, Department of Oncology, Aarhus 
C, Denmark  
 
A dream career in medical physics must be actively shaped by 
being pro-active, making good choices and exploiting 
opportunities. 
You need to know your field: 
A good career is based on the development of expertise in a 
multidisciplinary setting involving physics, oncology, and 
radiobiology. Regardless whether you are foreseeing a career 
in the direction of e.g. clinics, research, product 
development or administration: broad clinical medical 
physics training will always give you a sound insight in clinical 
workflows as well as importance/relevance/potential of new 
developments. Research training as accomplished during a 
PhD study will complement your clinical training. Explore 
opportunities at you University and at other Universities. 
Basic and advanced education within radiation therapy is 
available through ESTRO. This is an excellent opportunity to 
receive education of high quality and relevance. In 
particular: look out for the Physics Master Course which is 
taking place for the first time in autumn 2015. At ESTRO 
courses you will meet faculty and peers who may become 
professional partners and good friends. 
You need to do choose your field: 
When choosing a field, you need to take into account the 
relevance over the next decades. What has potential in your 
own department? Do your interests fit with current activities 
in your department? What has interest and potential on the 
international scene? Think in terms of the impact your 
research and developments would have: 1) How many 
patients are treated? 2) What are the prospects over the next 
years? 3) How can your research change clinical practice? 
Finally, choose your field field with passion! 
You need to know people:  
Networking inside and outside your institution is of immense 
importance for your development. Most of us are working in 
highly specialized fields, and you will have benefit from 
finding peers who have the same interests across 
departments and countries. Long or short term exchanges 
increases your network, and broadens your view. Look out for 
job opportunities abroad. Do not hesitate to write emails to 
colleagues with your CV and your interests. Furthermore, 
ESTRO has multiple activities where enthusiastic young 
people are highly appreciated for contributing to projects.  
You need to exploit and create opportunities: 
A great CV is not only a bunch of publications. Collaborative 
and organisational talents and experience is of high value in 
modern departments of Medical Physics. Your active 
contribution to your department and internationally creates 
the best opportunities.Such contributions may be in terms of 
e.g. coordination of projects/meetings, doing measurements, 
support of your mentors, and helping peers. Knock the door 
of the Professor and ask ”What can I do to contribute?”. The 
best investments for your career are often on the long term 
and will not readily show up on your CV.  
   
SP-0513   
A clinician’s perspective  
S.E. Combs1 
1Klinikum Rechts der Isar, Department of Radiation 
Oncology, Munich, Germany  
  
When finishing medical school and starting to work as a 
physician, there are many paths you can follow: Besides pure 
research work or movement into industry, clincial work is 
probably the most classical road to take after completing 
medical studies. However, although it can be the most 
rewarding, becoming a (successful) clinician can be the most 
demanding task. 
For every beginner in medicine and/or research, it is 
essential to evaluate the different prespectives, and to 
define your personal goals. During residency, a main priority 
is to become an excellent clinician, to acquire the knowledge 
to treat every patient in the best way. Keeping „up to date“ 
and integrating novel data and results into daily practice is 
essential. Moreover, especially in the University setting, 
clinical but perhaps also preclinical projects are a main part 
oft he daily tasks. 
After defining your personal goal and objectives, it is 
necessary to re-define your perspective, re-evaluate your 
personal achievements, and re-adjust your focus regularly 
along the road. In this context, it is equally important to 
keep to your personal budget in terms of Quality of Life 
(QOL), Work-Life-Balance as well as other personal interests. 
In spite of all personal planning and organization, an 
effective work surrounding as  well as a mentor, teacher, 
supporter... are not only helpful, but vital. 
